Stylianos Michalakis

Stylianos Michalakis

Company: ViGeneron

Job title: Co-founder & Chief Scientific Advisor


Addressing the Unmet Need in Retinal Gene Therapy: Focus on IVT Delivery & Cargo capacity of AAV Vectors 2:25 pm

Overview of the benefits and limitations of AAV vectors and unmet needs in retinal gene therapy Introduction and update on next generation vgAAV-AAV capsids Introduction to REVeRT dual AAV technologyRead more

day: Day One Track A - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.